ReP USP - Resultado da busca

Artigo de periodico
Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines (2020)
Cesena, Fernando H Y; Valente, Viviane A; Santos Filho, Raul Dias dos ; Bittencourt, Márcio Sommer
Fonte: Arquivos Brasileiros de Cardiologia. Unidades: FM, HU
Assuntos: DOENÇAS CARDIOVASCULARES, DISLIPIDEMIAS, ARTERIOSCLEROSE, FATORES DE RISCO, PREVENÇÃO PRIMÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H Y et al. Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines. Arquivos Brasileiros de Cardiologia, v. 115, n. 3, p. se 2020, 2020Tradução . . Disponível em: https://doi.org/10.36660/abc.20190519. Acesso em: 16 nov. 2024.
APA
Cesena, F. H. Y., Valente, V. A., Santos Filho, R. D. dos, & Bittencourt, M. S. (2020). Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines. Arquivos Brasileiros de Cardiologia, 115( 3), se 2020. doi:10.36660/abc.20190519
NLM
Cesena FHY, Valente VA, Santos Filho RD dos, Bittencourt MS. Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 115( 3): se 2020.[citado 2024 nov. 16 ] Available from: https://doi.org/10.36660/abc.20190519
Vancouver
Cesena FHY, Valente VA, Santos Filho RD dos, Bittencourt MS. Cardiovascular risk and statin eligibility in primary prevention: a comparison between the Brazilian and the AHA/ACC Guidelines [Internet]. Arquivos Brasileiros de Cardiologia. 2020 ; 115( 3): se 2020.[citado 2024 nov. 16 ] Available from: https://doi.org/10.36660/abc.20190519
Artigo de periodico-carta/editorial
Statin dose in primary prevention: aim for the target! [Editorial] (2019)
Bittencourt, Márcio Sommer; Cesena, Fernando H Y
Fonte: BMJ. Unidade: HU
Assuntos: ESTATINAS, ARTERIOSCLEROSE CORONÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer e CESENA, Fernando H Y. Statin dose in primary prevention: aim for the target! [Editorial]. BMJ. London: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1136/heartjnl-2019-314723. Acesso em: 16 nov. 2024. , 2019
APA
Bittencourt, M. S., & Cesena, F. H. Y. (2019). Statin dose in primary prevention: aim for the target! [Editorial]. BMJ. London: Hospital Universitário, Universidade de São Paulo. doi:10.1136/heartjnl-2019-314723
NLM
Bittencourt MS, Cesena FHY. Statin dose in primary prevention: aim for the target! [Editorial] [Internet]. BMJ. 2019 ; 105( 13): 969-971.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1136/heartjnl-2019-314723
Vancouver
Bittencourt MS, Cesena FHY. Statin dose in primary prevention: aim for the target! [Editorial] [Internet]. BMJ. 2019 ; 105( 13): 969-971.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1136/heartjnl-2019-314723
Artigo de periodico
Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? (2018)
Cesena, Fernando H Y; Laurinavicius, Antonio Gabriele; Valente, Viviane A; Conceição, Raquel D; Santos, Raul D; Bittencourt, Márcio Sommer
Fonte: Clinical Cardiology. Unidade: HU
Assuntos: HIPERCOLESTEROLEMIA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H Y et al. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level?. Clinical Cardiology, v. 41, n. 3, p. 333-338, 2018Tradução . . Disponível em: https://doi.org/10.1002/clc.22868. Acesso em: 16 nov. 2024.
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2018). Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? Clinical Cardiology, 41( 3), 333-338. doi:10.1002/clc.22868
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? [Internet]. Clinical Cardiology. 2018 ; 41( 3): 333-338.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/clc.22868
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? [Internet]. Clinical Cardiology. 2018 ; 41( 3): 333-338.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/clc.22868
Artigo de periodico
Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt (2018)
Cesena, Fernando H Y; Laurinavicius, Antonio G; Valente, Viviane A; Conceição, Raquel D; Nasir, Khurram; Santos, Raul D; Bittencourt, Márcio Sommer
Fonte: American Journal of Cardiology. Unidade: HU
Assuntos: INIBIDORES QUÍMICOS, ARTERIOSCLEROSE, RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H Y et al. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt. American Journal of Cardiology, v. 121, n. ju 2018, p. 1315-1320, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2018.02.011. Acesso em: 16 nov. 2024.
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Nasir, K., Santos, R. D., & Bittencourt, M. S. (2018). Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt. American Journal of Cardiology, 121( ju 2018), 1315-1320. doi:10.1016/j.amjcard.2018.02.011
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Nasir K, Santos RD, Bittencourt MS. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt [Internet]. American Journal of Cardiology. 2018 ; 121( ju 2018): 1315-1320.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Nasir K, Santos RD, Bittencourt MS. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt [Internet]. American Journal of Cardiology. 2018 ; 121( ju 2018): 1315-1320.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011
Trabalho de evento-resumo periodico
Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients (2016)
Cesena, Fernando H Y; Laurinavicius, Antonio; Bittencourt, Márcio Sommer; Conceição, Raquel; Santos, Raul
Fonte: Journal of the American College of Cardiology. Nome do evento: Annual Scientific Session and Expo - American College of Cardiology. Unidade: HU
Assuntos: DIABETES MELLITUS, COLESTEROL, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H Y et al. Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. Disponível em: http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S. Acesso em: 16 nov. 2024. , 2016
APA
Cesena, F. H. Y., Laurinavicius, A., Bittencourt, M. S., Conceição, R., & Santos, R. (2016). Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients. Journal of the American College of Cardiology. New York: Hospital Universitário, Universidade de São Paulo. Recuperado de http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S
NLM
Cesena FHY, Laurinavicius A, Bittencourt MS, Conceição R, Santos R. Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 13 supl.): 1961.[citado 2024 nov. 16 ] Available from: http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S
Vancouver
Cesena FHY, Laurinavicius A, Bittencourt MS, Conceição R, Santos R. Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients [Internet]. Journal of the American College of Cardiology. 2016 ; 67( 13 supl.): 1961.[citado 2024 nov. 16 ] Available from: http://www-sciencedirect-com.ez67.periodicos.capes.gov.br/science/journal/07351097/67/13/supp/S

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em